These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1314812)

  • 1. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Kaneko M; Sakata Y; Matsuda M; Mimuro J
    J Biochem; 1992 Feb; 111(2):244-8. PubMed ID: 1314812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activator.
    Kaneko M; Mimuro J; Matsuda M; Sakata Y
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1160-6. PubMed ID: 1908232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.
    Berg DT; Burck PJ; Berg DH; Grinnell BW
    Blood; 1993 Mar; 81(5):1312-22. PubMed ID: 8382971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of peptides on the inactivation of tissue plasminogen activator by plasminogen activator inhibitor-1 and on the binding of tissue plasminogen activator to endothelial cells.
    Wittwer AJ; Sanzo MA
    Thromb Haemost; 1990 Oct; 64(2):270-5. PubMed ID: 2125376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
    Wojta J; Beckmann R; Turcu L; Wagner OF; van Zonneveld AJ; Binder BR
    J Biol Chem; 1989 May; 264(14):7957-61. PubMed ID: 2470738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1.
    Mimuro J; Kaneko M; Murakami T; Matsuda M; Sakata Y
    Biochim Biophys Acta; 1992 Dec; 1160(3):325-34. PubMed ID: 1477106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA.
    Cheng XF; Brohlin M; Pohl G; Bäck O; Wallén P
    Thromb Res; 1995 Jan; 77(2):149-64. PubMed ID: 7740507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
    van Zonneveld AJ; Veerman H; Pannekoek H
    J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
    de Serrano VS; Castellino FJ
    J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
    Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
    J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
    Nesheim M; Fredenburgh JC; Larsen GR
    J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.
    Chmielewska J; Rånby M; Wiman B
    Biochem J; 1988 Apr; 251(2):327-32. PubMed ID: 3135797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.
    Lindahl TL; Ohlsson PI; Wiman B
    Biochem J; 1990 Jan; 265(1):109-13. PubMed ID: 2105714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.
    Lubin IM; Caban R; Runge MS
    J Biol Chem; 1993 Mar; 268(8):5550-6. PubMed ID: 8449917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution.
    Reilly CF; Hutzelmann JE
    J Biol Chem; 1992 Aug; 267(24):17128-35. PubMed ID: 1512250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
    Urano T; Takada Y; Takada A
    Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
    J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.